Cellebrite DI's (CLBT) board has approved a corporate reorganization, under which it will establish a new US corporation as its ultimate parent company, according to a Monday statement.
Redomiciling in the US is expected to better position the company in its key customer segments, Cellebrite DI CEO Shiv Ramji said.
The redomiciliation is expected to be completed in H1 2027, subject to shareholder and regulatory approvals.
Cellebrite DI shares were up more than 3% in early Monday trading.
Price: $11.52, Change: $+0.29, Percent Change: +2.58%